<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Oxford Chemistry</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/25E12FCE-4CAD-49BE-B598-64113F4D6C77"><gtr:id>25E12FCE-4CAD-49BE-B598-64113F4D6C77</gtr:id><gtr:firstName>Edward</gtr:firstName><gtr:otherNames>Alexander</gtr:otherNames><gtr:surname>Anderson</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FE055273%2F1"><gtr:id>F9A52610-67F5-4EFE-A0EE-1E9CA358269B</gtr:id><gtr:title>From Total Synthesis-Inspired Methodology to Anti-HIV therapy</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>EP/E055273/1</gtr:grantReference><gtr:abstractText>Organic chemistry provides a bridge between the physical world of atoms, molecules and their reactions, and the biological sciences, with one area of particular importance being the development of new medicines. Many drugs are originally inspired by 'natural products' / molecules refined by Nature over millions of years, which can have potent, specific biological activity against human diseases. As such, natural products represent highly advanced starting points for pharmaceutical research; however, their development as drug leads can be hampered by low natural abundance. One solution (which avoids decimation of the natural habitat) is the artificial preparation, or 'total synthesis' of the natural product. Historically, this process can take many years, a timescale which cannot satisfy the requirements of automated pharmaceutical screening. However, the application of improved, efficient chemical methods which enable rapid and scalable syntheses of these natural medicines (and non-natural 'analogues' with improved efficacy), is now an aim that is within the grasp of the organic chemist. Natural products chemistry thus stands on the brink of being re-embraced by the pharmaceutical community; this proposal aims to show that the natural product target itself is just the beginning of what an organic chemist can deliver.Traditionally, organic chemistry can be divided into two schools of research. The development of new reactions, which is fundamental to improving the efficiency of chemical synthesis, investigates new ways to form bonds between atoms. Often there is no specific target, and researchers can resort to scouring a vast array of natural products for one which will showcase their methodology. By contrast, in the field of total synthesis of structurally challenging molecules (which provides the ultimate testing ground for methodology), chemists tend to use known methods to forge the most efficient path they are able to a given target. The challenge of synthesis itself usually dictates that the choice of reaction is one with precedent and reliability.This proposal seeks to reverse this accepted order of reaction development: Natural products are seen as the inspiration for new reactions, rather than an arbitrary setting. Biologically important targets will be selected, and provide the impetus for the invention of an efficient and appealing synthetic transformation. Following development in a general setting, this method will then be applied in the context it was intended / a total synthesis of the natural product and analogues. Two projects which demonstrate the potential for natural products to initiate the development of useful, general reactions with broad applicability are proposed: Cepacin A, a potent antibiotic which contains an intriguing unsaturation motif, is the inspiration for a novel synthesis of chiral allenes. Lancifodilactone G and rubriflordilactone A, which possess anti-HIV properties, are the basis for an innovative route to bi- or tricyclic molecules.My proposal also details a collaborative project towards new methods for HIV inhibition. A currently uninvestigated area of the HIV life cycle is the 'packaging' of viral RNA into new virus particles. Packaging is initiated by binding of the viral protein Gag to a region of the viral RNA called psi. It is known that psi, and a truncated analogue, are bound specifically by a region of Gag that contains amino acids with nucleophilic sidechains. We intend to design psi analogues containing an electrophilic site, which will bind to Gag and place this site in proximity to the nucleophilic sidechain amino acids, leading to the formation of a covalent bond, irreversible binding of Gag, and inhibition of packaging. This is an exciting and unexplored area of chemical biology which harnesses the expertise of both the organic chemist and the virologist, and could have implications for the design of inhibitors for other virus specific RNA-protein interactions.</gtr:abstractText><gtr:fund><gtr:end>2012-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2007-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>666639</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Chemistry at the Garden</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>22ADF8C3-61C7-4BE6-9DDD-099328E05B78</gtr:id><gtr:impact>A public engagement exercise at the Oxford University Botanic Garden featuring poster exhibitions, self-guided audio trails, and guided walks by the PI on this grant.

Increased public awareness of the role of chemistry in society; increased public awareness of state of the art in the subject; increased public awareness of the chemicals found in plants, and the properties the exhibit.</gtr:impact><gtr:outcomeId>r-1552889609.2929780bb2a02c</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010,2012,2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Syngenta</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>Syngenta</gtr:fundingOrg><gtr:fundingRef>Industrial CASE award</gtr:fundingRef><gtr:id>64422E9B-2916-4A04-AC08-5D355FDFBBA5</gtr:id><gtr:outcomeId>5ec4fc545ec4fc72</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Pfizer</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Pfizer Ltd</gtr:fundingOrg><gtr:fundingRef>CASE Award</gtr:fundingRef><gtr:id>C81CB7BA-4821-4D49-B07F-B208CC122CB7</gtr:id><gtr:outcomeId>5ec49bb05ec49bc4</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Pfizer</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Pfizer Ltd</gtr:fundingOrg><gtr:fundingRef>CASE Award</gtr:fundingRef><gtr:id>B9B3FFF2-72FF-4A80-A88B-292880352F04</gtr:id><gtr:outcomeId>r-9875796316.07588068f145c</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>AstraZeneca</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>AstraZeneca</gtr:fundingOrg><gtr:fundingRef>CASE Award</gtr:fundingRef><gtr:id>9C4556A3-156E-4F2C-80E5-0DBF73C9F9F2</gtr:id><gtr:outcomeId>5ec1ca665ec1ca7a</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>AstraZeneca</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>AstraZeneca</gtr:fundingOrg><gtr:fundingRef>CASE Award</gtr:fundingRef><gtr:id>E7ECE03B-9B16-4F85-B8DC-909FF609DCC6</gtr:id><gtr:outcomeId>r-6750857687.323222068b9732</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>237124</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>RCs</gtr:description><gtr:end>2015-01-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/K005391/1</gtr:fundingRef><gtr:id>EFBF07A9-6D11-4DFA-807E-A2359D8C54D1</gtr:id><gtr:outcomeId>5edbd8ca5edbd8de</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Syngenta</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>Syngenta</gtr:fundingOrg><gtr:fundingRef>Industrial CASE award</gtr:fundingRef><gtr:id>1BB1EAA6-BA0B-4714-B9D9-887992C61AA8</gtr:id><gtr:outcomeId>r-4064201986.476967069f7c98</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>This grant has led to advances in several synthetic methodolgies, for the formation of organic ring systems, phenols, silanes, nitrogen-containing building blocks, allenes, oxacycles. It has also advanced general strategy in the total synthesis of bioactive natural products. This information will be of wide general use throughout the chemistry community. It has also provided training to numerous PhD students over the 5 year period, and undergraduate project students. These co-workers have gone on to a variety of professions, most of which are chemistry / science related (e.g. academic research (PhD or PDRA), industrial research, patent law, science teachers).

Beneficiaries: Scientific community (academic and industry); UK economy (chemistry research, business sector through trained co-workers); public (through outreach activities)

Contribution Method: See comments above.</gtr:description><gtr:firstYearOfImpact>2011</gtr:firstYearOfImpact><gtr:id>4352C80E-C6A0-4C6E-9F8B-3ABE52092126</gtr:id><gtr:impactTypes><gtr:impactType>Cultural</gtr:impactType></gtr:impactTypes><gtr:outcomeId>m-135468682.40038744de247d4c</gtr:outcomeId><gtr:sector>Chemicals,Healthcare,Leisure Activities, including Sports, Recreation and Tourism</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We developed new ways to build molecules using transition metals to catalyse bond formations. This is important as it contributes to efficiency and therefore low cost synthesis, which is a key aim of modern synthetic chemistry. Specifically, we developed new ways to make all-carbon, and oxygen- or nitrogen-containing organic ring systems, which represent useful 3D building blocks for organic chemistry. Importantly, this reactivity could be achieved with high yields and selectivity - in other words, single products rather than mixtures could be targted. Our synthesis of bioactive natural products is an ongoing area of research, which through the initial work carried out on this grant is now close to realising completed total syntheses of these challenging structures. In many cases, this includes implementing catalysis in settings of unprecedented complexity, thus advancing the state of the art of synthetic organic chemistry.</gtr:description><gtr:exploitationPathways>The work carried out on this grant led to several industrial collaborations, such as part sponsorship of PhD students. This then enabled communication of our work to industrial settings. We continue to engage with these end users through ongoing projects.</gtr:exploitationPathways><gtr:id>91D71EBF-F44E-4D28-B350-5F65D9565FD8</gtr:id><gtr:outcomeId>5457966a355e37.78249219</gtr:outcomeId><gtr:sectors><gtr:sector>Chemicals,Healthcare</gtr:sector></gtr:sectors><gtr:url>http://anderson.chem.ox.ac.uk/</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>F8899FD9-9C4B-4E3C-97BA-E137661DDD9D</gtr:id><gtr:title>Synthesis of Vinylsilanes</gtr:title><gtr:parentPublicationTitle>Synthesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d550d24dab1dc4fea4432bd490459c73"><gtr:id>d550d24dab1dc4fea4432bd490459c73</gtr:id><gtr:otherNames>Anderson E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>doi_53d0320324321781</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F39AB01-E1E7-4E07-A462-F5248C991C58</gtr:id><gtr:title>Palladium-catalyzed asymmetric synthesis of 2-alkynyl oxacycles.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a351df6e052bf25380e24b8434f71ebe"><gtr:id>a351df6e052bf25380e24b8434f71ebe</gtr:id><gtr:otherNames>Daniels DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn><gtr:outcomeId>doi_53cfc1fc16f3b7da</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E50F481-CB48-448B-AE7E-4596F6379342</gtr:id><gtr:title>Enantioselective synthesis of the predominant AB ring system of the Schisandra nortriterpenoid natural products.</gtr:title><gtr:parentPublicationTitle>Organic letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b19ec68b369851232f2ec7eb94e27008"><gtr:id>b19ec68b369851232f2ec7eb94e27008</gtr:id><gtr:otherNames>Gockel B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1523-7052</gtr:issn><gtr:outcomeId>5463d85ce57318.02775136</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F65507CA-6653-4450-91D1-E1DBD1376655</gtr:id><gtr:title>Recent advances in the use of temporary silicon tethers in metal-mediated reactions.</gtr:title><gtr:parentPublicationTitle>Chemical Society reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27a329d28a373f79ec3a836b10e8dc65"><gtr:id>27a329d28a373f79ec3a836b10e8dc65</gtr:id><gtr:otherNames>Bracegirdle S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0306-0012</gtr:issn><gtr:outcomeId>doi_53d02d02d02bf7d8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0039367-4106-4FFF-A8D0-D27F67BF0A77</gtr:id><gtr:title>Reductive Cyclization of Bromoenynamides with Alcohols as Hydride Source: Synthesis and Reactions of 2-Amidodienes</gtr:title><gtr:parentPublicationTitle>Advanced Synthesis &amp; Catalysis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/951b3b88c17ca2359f04e825b0a3d402"><gtr:id>951b3b88c17ca2359f04e825b0a3d402</gtr:id><gtr:otherNames>Greenaway R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>doi_53cfc0fc0417f210</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD829101-A454-401D-8E58-E32F9B29BBFC</gtr:id><gtr:title>Total Synthesis of (+)-Rubriflordilactone&amp;acirc;? A.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59ab0ca0f94e4a15ff650ef384712a28"><gtr:id>59ab0ca0f94e4a15ff650ef384712a28</gtr:id><gtr:otherNames>Goh SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn><gtr:outcomeId>56dde962ad64e1.90289807</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B259C3A5-D191-4BA2-B56B-38AF2E59FD2E</gtr:id><gtr:title>Synthesis of phenols via fluoride-free oxidation of arylsilanes and arylmethoxysilanes.</gtr:title><gtr:parentPublicationTitle>The Journal of organic chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/869c8ac0d58cce7569c2cf7e132e2568"><gtr:id>869c8ac0d58cce7569c2cf7e132e2568</gtr:id><gtr:otherNames>Rayment EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3263</gtr:issn><gtr:outcomeId>doi_53d0180186e59d93</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E1FE4AF-2441-4C3B-9F60-1A5D4EBCD57B</gtr:id><gtr:title>Totalsynthese von (+)-Rubriflordilacton A</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/497e720e4eee6d37b1f2cc30e304db53"><gtr:id>497e720e4eee6d37b1f2cc30e304db53</gtr:id><gtr:otherNames>Goh S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>585d58750707f8.72761030</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E94D7BD-4D8C-43B3-A967-4E79BB684AAB</gtr:id><gtr:title>A palladium-mediated cascade cyclisation approach to the CDE cores of rubriflordilactone A and lancifodilactone G.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8aad3cd502b848d6621cc802d0f8f34e"><gtr:id>8aad3cd502b848d6621cc802d0f8f34e</gtr:id><gtr:otherNames>Cordonnier MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>doi_53d02b02b1887ee3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BAFC47DC-CFBB-4889-A774-F69E9E12F32C</gtr:id><gtr:title>Mechanistic Study of Arylsilane Oxidation throughF NMR Spectroscopy.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/869c8ac0d58cce7569c2cf7e132e2568"><gtr:id>869c8ac0d58cce7569c2cf7e132e2568</gtr:id><gtr:otherNames>Rayment EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>5a2fec079713f1.22920388</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1798070B-9A06-488B-A3DC-B19B7ACD9B3C</gtr:id><gtr:title>Synthesis of cyclic alkenylsiloxanes by semihydrogenation: a stereospecific route to (Z)-alkenyl polyenes.</gtr:title><gtr:parentPublicationTitle>Chemistry (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7cf408535fa34316801e5811d1c2110c"><gtr:id>7cf408535fa34316801e5811d1c2110c</gtr:id><gtr:otherNames>Elbert BL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0947-6539</gtr:issn><gtr:outcomeId>5463d85d13eae4.62774346</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>380D378D-983C-4ED8-8B9D-FA1F0168B2AD</gtr:id><gtr:title>One-step preparation of functionalized (E)-vinylsilanes from aldehydes.</gtr:title><gtr:parentPublicationTitle>Organic letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2d016bf939cea5d45e3fe5cff0e5634"><gtr:id>a2d016bf939cea5d45e3fe5cff0e5634</gtr:id><gtr:otherNames>Lim DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1523-7052</gtr:issn><gtr:outcomeId>doi_53d01c01c013daf1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B55C4DF-EE98-41CE-A882-228F12EB1CED</gtr:id><gtr:title>Ligand bite angle-dependent palladium-catalyzed cyclization of propargylic carbonates to 2-alkynyl azacycles or cyclic dienamides.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a351df6e052bf25380e24b8434f71ebe"><gtr:id>a351df6e052bf25380e24b8434f71ebe</gtr:id><gtr:otherNames>Daniels DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn><gtr:outcomeId>5463d85e5ccc79.32125090</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0B54226-ABC6-44D0-B9B2-8A6D711FFD7A</gtr:id><gtr:title>A cascade palladium-mediated cross-coupling/electrocyclization approach to the construction of fused bi- and tricyclic rings.</gtr:title><gtr:parentPublicationTitle>Organic letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4c6cd40a1f5b67c7013c377ed2b910e"><gtr:id>f4c6cd40a1f5b67c7013c377ed2b910e</gtr:id><gtr:otherNames>Kan SB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1523-7052</gtr:issn><gtr:outcomeId>doi_53d01c01c1dba3f2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB1FD6F3-65A8-4DDE-8820-5B2B8A5791FF</gtr:id><gtr:title>Palladium- and ruthenium-catalyzed cycloisomerization of enynamides and enynhydrazides: a rapid approach to diverse azacyclic frameworks.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3fd1806388aa179d80a27a23697fd356"><gtr:id>3fd1806388aa179d80a27a23697fd356</gtr:id><gtr:otherNames>Walker PR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn><gtr:outcomeId>doi_53cfc1fc1a8200f2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D18D0D9-27F1-4CF3-8385-DC88699CD093</gtr:id><gtr:title>Metal-catalyzed syntheses of abridged CDE rings of rubriflordilactones A and B.</gtr:title><gtr:parentPublicationTitle>Organic letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59ab0ca0f94e4a15ff650ef384712a28"><gtr:id>59ab0ca0f94e4a15ff650ef384712a28</gtr:id><gtr:otherNames>Goh SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1523-7052</gtr:issn><gtr:outcomeId>doi_53d01c01c0caeda4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A46D85D0-8855-4C9A-9F16-4D0C41253508</gtr:id><gtr:title>Palladium-catalyzed cyclization of bromoenynamides to tricyclic azacycles: synthesis of trikentrin-like frameworks.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3600a3525eb9a0cadcd2d7f8389bb046"><gtr:id>3600a3525eb9a0cadcd2d7f8389bb046</gtr:id><gtr:otherNames>Campbell CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>5463d85e817ba5.44512204</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1AE8884-2F18-47BF-8242-6F6B7C906FFB</gtr:id><gtr:title>Carbopalladation of bromoene-alkynylsilanes: mechanistic insights and synthesis of fused-ring bicyclic silanes and phenols</gtr:title><gtr:parentPublicationTitle>Org. Chem. Front.</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1b79d4ecc3fbd17269ca7daaa9e8316"><gtr:id>e1b79d4ecc3fbd17269ca7daaa9e8316</gtr:id><gtr:otherNames>Cordonnier M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>5463d85d38eae7.16902714</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1666D893-577E-47AD-88E6-2A1490D98F8A</gtr:id><gtr:title>Arylsilane oxidation--new routes to hydroxylated aromatics.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27a329d28a373f79ec3a836b10e8dc65"><gtr:id>27a329d28a373f79ec3a836b10e8dc65</gtr:id><gtr:otherNames>Bracegirdle S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>doi_53d02c02c5132f8a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF032D7A-8FA2-4847-B525-C4B5B0A508A6</gtr:id><gtr:title>Cascade polycyclisations in natural product synthesis.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc3500fe69db8c3c0975209189e492aa"><gtr:id>fc3500fe69db8c3c0975209189e492aa</gtr:id><gtr:otherNames>Anderson EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn><gtr:outcomeId>doi_53d02e02e7eb0ca4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E06E6A6D-1914-44EC-B8AE-73CA2B7BBF15</gtr:id><gtr:title>Palladium-catalyzed cascade cyclization of ynamides to azabicycles.</gtr:title><gtr:parentPublicationTitle>Chemistry (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ffc486e553ef531134092126a700a9c7"><gtr:id>ffc486e553ef531134092126a700a9c7</gtr:id><gtr:otherNames>Greenaway RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0947-6539</gtr:issn><gtr:outcomeId>doi_53cfc3fc30caca0d</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/E055273/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>60EBB420-734E-4DB5-B0F2-65A1115A27F8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Chemical synthesis</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>0B9701E7-D17F-4963-82DA-B3926A65B50A</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Biological &amp; Medicinal Chem.</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>